The global automated breast ultrasound systems market size is estimated to hit around USD 9.84 billion by 2033 from USD 2.31 billion in 2023 with a CAGR of 15.59% from 2024 to 2033.
Key Points
- North America dominated the automated breast ultrasound systems market with the largest share in 2023.
- Asia Pacific is observed to witness the fastest rate of growth during the forecast period.
- By product, the automated breast ultrasound scanner segment has contributed the largest market share of in 2023.
- By product, the automated breast volume scanner combination therapy segment is observed to witness a notable rate of growth during the forecast period.
- By end user, the radiologists segment dominated the market in 2023.
- By end user, the surgeon segment is projected to witness rapid growth in the upcoming years.
The automated breast ultrasound systems market is experiencing significant growth due to the rising prevalence of breast cancer worldwide. Automated breast ultrasound systems (ABUS) offer advantages such as enhanced imaging quality, reduced examination time, and improved accuracy in detecting breast abnormalities compared to traditional mammography. These systems are increasingly being adopted as adjunctive screening tools for women with dense breast tissue, where mammography may be less effective. The market for ABUS is also driven by technological advancements, increasing awareness about early breast cancer detection, and initiatives by healthcare organizations to improve breast cancer screening programs.
Get a Sample: https://www.precedenceresearch.com/sample/3925
Growth Factors
Several factors are contributing to the growth of the automated breast ultrasound systems market. Firstly, the rising incidence of breast cancer globally is a significant driver, leading to an increased demand for advanced screening technologies like ABUS. Additionally, the growing awareness about the limitations of mammography in detecting breast cancer in women with dense breast tissue is fueling the adoption of ABUS as a complementary screening tool. Technological advancements in ABUS systems, such as improved image resolution, faster scanning times, and enhanced automation, are also driving market growth. Furthermore, favorable reimbursement policies for ABUS procedures in some regions are encouraging healthcare providers to incorporate these systems into their breast cancer screening protocols.
Region Insights:
The market for automated breast ultrasound systems is segmented into various regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America currently dominates the market, primarily due to the high prevalence of breast cancer, well-established healthcare infrastructure, and favorable reimbursement policies. Europe is also a significant market for ABUS, driven by increasing awareness about breast cancer screening and growing investments in healthcare technology. The Asia-Pacific region is expected to witness the fastest growth, attributed to rising healthcare expenditure, increasing adoption of advanced medical imaging technologies, and improving access to healthcare services in emerging economies.
Automated Breast Ultrasound Systems Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 15.59% |
| Global Market Size in 2023 | USD 2.31 Billion |
| Global Market Size by 2033 | USD 9.84 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product and By End-user |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Automated Breast Ultrasound Systems Market Dynamics
Drivers:
Several drivers are propelling the growth of the automated breast ultrasound systems market. The primary driver is the increasing incidence of breast cancer globally, particularly in developed countries. Rising awareness about the importance of early detection and screening for breast cancer is also driving demand for ABUS systems. Moreover, technological advancements in ABUS technology, such as the development of 3D automated breast ultrasound systems and artificial intelligence-based image analysis software, are enhancing the efficiency and accuracy of breast cancer detection. Additionally, collaborations and partnerships between medical device companies and healthcare providers to promote ABUS adoption are further driving market growth.
Opportunities:
The automated breast ultrasound systems market presents several opportunities for growth and innovation. One such opportunity lies in expanding market penetration in emerging economies where breast cancer screening infrastructure is still developing. There is also potential for the development of more affordable and portable ABUS systems to increase accessibility in underserved regions. Furthermore, integrating ABUS technology with other imaging modalities, such as MRI and digital mammography, could improve diagnostic accuracy and patient outcomes. Additionally, ongoing research and development efforts to enhance the performance and capabilities of ABUS systems could lead to new opportunities for market expansion.
Challenges:
Despite the growth prospects, the automated breast ultrasound systems market faces several challenges. One challenge is the high initial cost of ABUS systems, which may limit adoption, particularly in resource-constrained healthcare settings. Additionally, concerns about overdiagnosis and false-positive results could impact physician acceptance and patient compliance with ABUS screening. Moreover, the lack of standardized protocols for ABUS imaging interpretation and reimbursement discrepancies across different regions pose challenges to market growth. Addressing these challenges will be crucial for realizing the full potential of automated breast ultrasound systems in improving breast cancer screening and diagnosis globally.
Read Also: Acne Medication Market Size to Surpass USD 19.17 Bn by 2033
Recent Developments
- In February 2024, Butterfly Network introduced the iQ3TM handheld ultrasound system, incorporating advanced image processing, artificial intelligence (AI) capabilities, and enhanced 3D imaging technology. This innovative device marks a significant milestone in ultrasound technology, offering healthcare professionals a portable and powerful tool for diagnostic imaging with improved accuracy and efficiency.
- In October 2023, Philips Healthcare unveiled a groundbreaking solution for breast ultrasound imaging, combining hardware and software into a cohesive package. Available on the company’s Epiq and Affiniti ultrasound scanners, this innovative offering integrates Philips’ PureWave eL18-4 ultra-broadband linear-array transducer with advanced ‘anatomical intelligence’ automated software.
Automated Breast Ultrasound Systems Market Companies
- ALPINION Medical Systems Co., Ltd.
- BK Medical Holding Company, Inc.
- Canon Medical Systems Corporation
- Delphinus Medical Technologies, Inc.
- Fukuda Denshi Co., Ltd.
- GE Healthcare
- Hitachi, Ltd.
- Hologic, Inc.
- Konica Minolta, Inc.
- Koninklijke Philips N.V.
- QT Imaging, Inc.
- Samsung Group
- Seno Medical Instruments, Inc.
- Siemens Healthineers AG
- SonoCine, Inc.
Segments Covered in the Report
By Product
- Automated Breast Ultrasound System
- Automated Breast Volume Scanner
- Automated Breast Ultrasound Device
- Automated Breast Imaging System
- Automated Breast Ultrasound Scanner
- Automated Breast Ultrasound Equipment
- Automated Breast Ultrasound Machine
- Automated Breast Ultrasound Technology
By End-user
- Radiologists
- Oncologists
- Breast Surgeons
- Gynecologists
- Breast Imaging Technologists
- Healthcare Providers
- Patients
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
